Exagen Inc. (XGN)

Last Closing Price: 6.95 (2025-05-30)

Earnings per Share (EPS) (Diluted) (Quarterly)

Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.

Exagen Inc. (XGN) had Earnings per Share (EPS) (Diluted) of $-0.20 for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$15.50M
$-3.75M
$6.38M
$9.12M
$18.86M
$-3.37M
$-0.39M
$-3.75M
$-3.75M
$-3.75M
$-3.75M
$-3.75M
$-3.75M
$-3.37M
$-2.88M
18.56M
18.56M
$-0.20
Earnings per Share (EPS) (Diluted)
$-0.20
Balance Sheet Financials
$32.51M
$5.03M
$7.79M
$40.29M
$13.99M
$18.41M
$19.90M
$33.89M
$6.40M
$6.40M
$6.40M
17.95M
Cash Flow Statement Financials
$-10.67M
$-0.11M
$-0.06M
$22.24M
$11.39M
$-10.84M
$0.42M
--
--
Fundamental Metrics & Ratios
2.32
--
--
0.74
3.27
58.87%
-21.71%
-21.71%
--
-24.21%
-24.21%
$-10.78M
--
--
--
0.38
--
1.05
85.53
-58.60%
-58.60%
-9.31%
-15.12%
$0.36
$-0.58
$-0.57